Genzyme To Pay $175M Over Drug Safety Violations
Genzyme Corp. has agreed to pay $175 million to the U.S. government as part of a consent deal to remedy manufacturing violations that caused drug safety problems including viral contamination at...To view the full article, register now.
Already a subscriber? Click here to view full article